Marc Moritz Berger

Heidelberg University — Germany

Biochemistry, Genetics and Molecular Biology · Life Sciences

38h-index7.8kcitations267works0.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

High Altitude and Hypoxia(61), Neuroscience of respiration and sleep(34), Hematological disorders and diagnostics(24), COVID-19 Clinical Research Studies(23), Sarcoma Diagnosis and Treatment(23)

Publications252 total

Safety and efficacy of inhaled PEG-ADM in ARDS patients: a randomised controlled trial
Critical Care·2025Open Access
Associations between COVID-19 incidence and environmental stressors in Brazil: a nationwide study from 2020 to 2022
Frontiers in Environmental Health·2025Open Access
Ignoble Gas: The Questionable Role of Xenon in Rapid Ascents of Mount Everest
High Altitude Medicine & Biology·2025
Improved pathogen identification in sepsis or septic shock by clinical metagenomic sequencing
Journal of Infection·2025· 3 citedOpen Access
Predictive value of early postoperative copeptin after cardiac surgery
European Journal of Anaesthesiology·2025
Akute Höhenerkrankungen
Anästhesie Nachrichten·2025
P-gp quantification for cell resistance studies in leukemia cells using the innovative LightSpot-FL-1 fluorescent conjugate
Scientific Reports·2025· 2 citedOpen Access
Das geriatrische Syndrom Frailty im Kontext der Wiederaufnahme auf der Intensivstation
Medizinische Klinik - Intensivmedizin und Notfallmedizin·2025Open Access
Improved pathogen identification in sepsis or septic shock by clinical metagenomic sequencing
2025Open Access
Breathing and Pulmonary Circulation at High Altitudes
Respiratory medicine·2025
Physiologie der mittleren, großen und extremen Höhen
2025Open Access
Von der Höhen- zur Intensivmedizin
2025
Akute Bergkrankheit
2025
Ketamine for Emergency Medicine in the Mountains and at High Altitude
Neuromethods·2025
Höhenlungenödem
2025
Analgesie im alpinen Gelände
2025
Höhenhirnödem
2025
Systematic assessment of COVID-19 host genetics using whole genome sequencing data
PLoS Pathogens·2024· 1 citedOpen Access
Heterogeneity of treatment effect of vilobelimab in COVID-19: a secondary analysis of a randomised controlled trial
Critical Care·2024· 6 citedOpen Access
Assessing heart rate fragmentation to predict atrial fibrillation in the general population aged 65
EP Europace·2024Open Access
page 1 of 13Next →

Frequent Co-authors

Peter Bärtsch(14), Thorsten Brenner(11), Heimo Mairbäurl(9), Oliver Witzke(8), Krystallenia Paniskaki(6), Sebastian Dolff(6), Timm H. Westhoff(6), Nina Babel(6), Christoph Dehnert(6), Andrew M. Luks(5), Erik R. Swenson(5), Ulf Dittmer(5), Damian M. Bailey(4), Elmar Menold(4), Mahdi Sareban(4), Markus W. Hollmann(3), Tobias Welte(3), Constantin J. Thieme(3), Moritz Anft(3), Arturo Blazquez‐Navarro(3)